Navigation Links
BeaconEquity.com Issues Trade Alerts on Biotechnology Stocks: ELN, PFE, AMGN, DNA, BIIB, GILD
Date:8/18/2008

DALLAS, Aug. 18 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today.

Investors can view all of the daily trading notes for free by visiting: http://www.BeaconEquity.com/m

Today's Trade Alerts include: Elan Corp. plc (NYSE: ELN), Pfizer Inc. (NYSE: PFE), Amgen Inc. (Nasdaq: AMGN), Genentech Inc. (NYSE: DNA), Biogen Idec Inc. (Nasdaq: BIIB) and Gilead Sciences Inc. (Nasdaq: GILD).

Join the fastest growing investment community at: http://www.stocknetworkonline.com

See what Cramer has to say about these stocks at: http://maddmoney.net/

BeaconEquity.com's Trade Alerts are brief analyses on the active stocks each day that are affecting the markets. These include breaking news, insider activity, recent 52-week highs/lows, technical breakouts, and other market driving information. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.

We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.BeaconEquity.com/m

BeaconEquity.com is one of the industry's largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.BeaconEquity.com/m CRD# 1755680

BeaconEquity.com Disclosure

BeaconEquity.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BeaconEquity.com is a wholly owned entity of BlueWave Advisors, LLC. Please read our report and visit our website, BeaconEquity.com, for complete risks and disclosures.

Beacon Equity Research

Jeff Bishop, (469)-252-3505

press@beaconequity.com

Reuben Sushman of Beacon Equity Research is a member of the National Association of Securities Dealers, CRD number 1755680.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. JEFF BISHOP https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=70781


'/>"/>
SOURCE BeaconEquity.com
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Arbitration Panel Issues Ruling in Distribution Dispute
2. ActivBiotics Assignee Issues First Distribution of Cash to Creditors
3. Neuftec Issues Patent Infringement Proceedings in the UK Against Oxonica
4. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd.
5. Bristol-Myers Squibb Issues $1.6 Billion of Senior Notes
6. SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT
7. VaxGen Issues Rebuttal to MedCap Letter
8. pH Balanced RepHresh Vaginal Gel(R) now Available to Women in Canada Attacking Tough, Embarrassing Feminine Issues
9. FDA Issues Approvable Letter for Ceftobiprole for Treatment of Complicated Skin Infections
10. Medco Issues $1.5 Billion of Senior Notes
11. SectorWatch.biz Issues MarketStats on CVBT, BSX, MDT, CXM and DNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... PARK, Calif. , Dec. 6, 2016 /PRNewswire/ ... up to $150 million from the National Institutes ... Diseases and the Division of AIDS (NIAID-DAIDS) to ... and other non-vaccine pre-exposure (PreP) agents. Under the ... of preclinical product development services for candidate HIV-prevention ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... discovery and development of precision treatments for neurodegenerative diseases, today announced the ... (AD) inhibited the direct neurotoxic effect of prion-like forms of Amyloid beta ...
(Date:12/5/2016)... , Dec. 5, 2016 Axovant Sciences Ltd. ... company focused on the treatment of dementia, today announced ... the treatment of Alzheimer,s disease will be presented at ... on Friday, December 9, 2016 in San ... results of both simple and complex measures of activities ...
(Date:12/5/2016)... , Dec 5, 2016 Research ... "Biomarkers - Technologies, Markets and Companies" to their offering. ... , , ... and their discovery using various -omics technologies such as proteomics and ... and new tests are also based on biomarker. Currently ...
Breaking Biology Technology:
(Date:11/16/2016)... SANTA CLARA, Calif. , Nov. 16, 2016 /PRNewswire/ ... company enhancing user experience and security for consumer ... provider for the financial and retail industry, today ... more secure and convenient way to authenticate users ... now uses Sensory,s TrulySecure™ software which ...
(Date:11/14/2016)... Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), a ... challenging operating environments, announced its results for the third ... conference call to discuss these results on November 15, ... Key Recent Accomplishments The ... Vislink Communication Systems. The purchase is expected to close ...
(Date:6/22/2016)... -- The American College of Medical Genetics and Genomics was once ... one of the fastest-growing trade shows during the Fastest 50 ... Las Vegas . Winners ... each of the following categories: net square feet of paid ... The 2015 ACMG Annual Meeting was ranked 23 out of ...
Breaking Biology News(10 mins):